Loading organizations...
§ Private Profile · Culver City, CA, USA
Innovative biopharmaceuticals developing antibody-based cancer treatments.
TORL BioTherapeutics has raised $254.0M across 2 funding rounds.
TORL BioTherapeutics has raised $254.0M in total across 2 funding rounds.
TORL BioTherapeutics has raised $254.0M across 2 funding rounds. Most recently, it raised $96.0M Series C in October 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 7, 2025 | $96M Series C | — | — | Announced |
| Apr 13, 2023 | $158M Series B | Amit Sinha | Alexandria Venture Investments, Bristol Myers Squibb, Cowen Healthcare Investments, Deep Track Capital, OCV Partners, Perceptive Xontogeny Venture Fund, UC RNT Fund, Vertex Ventures HC | Announced |
TORL BioTherapeutics has raised $254.0M in total across 2 funding rounds.
TORL BioTherapeutics's investors include Amit Sinha, Alexandria Venture Investments, Bristol Myers Squibb, Cowen Healthcare Investments, Deep Track Capital, OCV Partners, Perceptive Xontogeny Venture Fund, UC-RNT Fund, Vertex Ventures HC.